As of 2026-04-01, the EV/EBITDA ratio of Carl Zeiss Meditec AG (AFX.DE) is 8.45. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AFX.DE's latest enterprise value is 2,724.99 mil EUR. AFX.DE's TTM EBITDA according to its financial statements is 322.35 mil EUR. Dividing these 2 quantities gives us the above AFX.DE EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 8.4x - 10.8x | 9.4x |
| Forward P/E multiples | 9.3x - 12.8x | 11.4x |
| Fair Price | 24.08 - 39.44 | 30.85 |
| Upside | -0.5% - 63.0% | 27.5% |
| Date | EV/EBITDA |
| 2026-04-01 | 8.50 |
| 2026-03-31 | 8.45 |
| 2026-03-30 | 8.49 |
| 2026-03-27 | 8.49 |
| 2026-03-26 | 8.68 |
| 2026-03-25 | 8.74 |
| 2026-03-24 | 8.39 |
| 2026-03-23 | 8.24 |
| 2026-03-20 | 8.27 |
| 2026-03-19 | 8.28 |
| 2026-03-18 | 8.28 |
| 2026-03-17 | 8.31 |
| 2026-03-16 | 8.29 |
| 2026-03-13 | 8.29 |
| 2026-03-12 | 8.29 |
| 2026-03-11 | 8.40 |
| 2026-03-10 | 8.62 |
| 2026-03-09 | 8.50 |
| 2026-03-06 | 8.69 |
| 2026-03-05 | 8.78 |
| 2026-03-04 | 8.92 |
| 2026-03-03 | 8.78 |
| 2026-03-02 | 8.90 |
| 2026-02-27 | 9.26 |
| 2026-02-26 | 9.31 |
| 2026-02-25 | 9.08 |
| 2026-02-24 | 9.10 |
| 2026-02-23 | 9.10 |
| 2026-02-20 | 9.20 |
| 2026-02-19 | 9.23 |
| 2026-02-18 | 9.28 |
| 2026-02-17 | 9.23 |
| 2026-02-16 | 8.91 |
| 2026-02-13 | 9.18 |
| 2026-02-12 | 8.81 |
| 2026-02-11 | 9.26 |
| 2026-02-10 | 9.56 |
| 2026-02-09 | 9.48 |
| 2026-02-06 | 9.37 |
| 2026-02-05 | 9.32 |
| 2026-02-04 | 9.42 |
| 2026-02-03 | 9.39 |
| 2026-02-02 | 9.46 |
| 2026-01-30 | 9.51 |
| 2026-01-29 | 9.52 |
| 2026-01-28 | 9.73 |
| 2026-01-27 | 9.42 |
| 2026-01-26 | 9.72 |
| 2026-01-23 | 9.61 |
| 2026-01-22 | 9.88 |